FAAN

NCSBN Award Ceremony Honors Outstanding Nurse Regulators

Retrieved on: 
Wednesday, August 23, 2023
RGN, FRE, Awards and decorations of the Civil Air Patrol, MSN, Nursing, Founder's Award, Public policy, Doctor of Philosophy, Kansas State Board of Nursing, Texas Meritorious Service Award, NCSBN, RN, Ethics, FRCN, FAAN

Chicago, Aug. 23, 2023 (GLOBE NEWSWIRE) -- NCSBN recognized its dedicated and exceptional membership and guests at its annual awards ceremony during the NCSBN Annual Meeting and Delegate Assembly, held in Chicago, Aug. 16-18, 2023.

Key Points: 
  • Chicago, Aug. 23, 2023 (GLOBE NEWSWIRE) -- NCSBN recognized its dedicated and exceptional membership and guests at its annual awards ceremony during the NCSBN Annual Meeting and Delegate Assembly, held in Chicago, Aug. 16-18, 2023.
  • David Benton, RGN, PhD, FRCN, FAAN, CEO, NCSBN, was awarded the prestigious Founders Award that is given only upon occasion that an individual with ethics, integrity and sincerity has demonstrated the highest regard for the ideals and beliefs upon which NCSBN was founded.
  • Paula R. Meyer, MSN, RN, FRE, retired executive director, Washington State Board of Nursing, received the Meritorious Service Award, which is granted to a member for significant contributions to the mission and vision of NCSBN.
  • Suzanne Hunt, board staff, Tennessee Board of Nursing, received the Exceptional Contribution Award, which is given for significant contribution by a member who is not a president or executive officer and has demonstrated support of NCSBN’s mission.

Dru Riddle Begins Term as President of the American Association of Nurse Anesthesiology

Retrieved on: 
Tuesday, August 22, 2023
Translation, Systematic review, Medical University of South Carolina, Bachelor of Science in Nursing, Health, ALL, Cochrane US Network, Lobbying, Anesthesiology, Old Dominion University, American Academy, Medical school, Research, Multimedia, Doctor of Philosophy, Professional practice of behavior analysis, Government, Certification, DNP, Texas Christian University, NorthStar, AANA, CRNA, Virginia Commonwealth University, Fortification, American Academy of Nursing, FAAN, Nursing, Science, Riddle

"Ultimately, the AANA is here to support ALL members regardless of practice model, years of certification, or geographic location.

Key Points: 
  • "Ultimately, the AANA is here to support ALL members regardless of practice model, years of certification, or geographic location.
  • As president, it is my job to make sure your board understands this and I look forward to leading this association into a bright future!"
  • Riddle is an associate professor of Professional Practice and director of Clinical Education at Texas Christian University School of Nurse Anesthesia in Fort Worth.
  • In addition to his research and teaching roles, Riddle maintains an active clinical anesthesia practice through NorthStar Anesthesia.

Frontier Nursing University Holds Preceptor Celebration Week to Honor Their Important Role in Advanced Practice Nursing

Retrieved on: 
Tuesday, August 15, 2023
Preceptor, Education, CNM, FNU, Blog, Social media, Student, FAAN, Nursing, Twitter

Versailles, KY, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Frontier Nursing University’s (FNU) first Preceptor Celebration Week is August 14-18, 2023.

Key Points: 
  • Versailles, KY, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Frontier Nursing University’s (FNU) first Preceptor Celebration Week is August 14-18, 2023.
  • This event honors the important role that preceptors play in advanced practice nursing education.
  • Preceptors are experienced licensed clinicians who supervise nursing students during their clinical rotations.
  • Their role is to help students translate what they have learned into real-world clinical practice.

C2N Diagnostics Releases the PrecivityAD2™ Blood Test for Clinical Care, a Robust Assay with High Concordance to Amyloid PET and CSF

Retrieved on: 
Thursday, August 17, 2023
Mental Health, Research, Clinical Trials, Biotechnology, Other Health, Health, General Health, Other Science, Science, Lund University, Laboratory developed test, Tulane University School of Medicine, LDT, Diagnosis, Chronic kidney disease, APS2, Cardiovascular disease, Pathology, Deficit spending, PET, Brain, Biomarker, Approximation error, Dementia, Amyloid, Plasma, Patient, C2N, Blood, AUC, Neurology, CSF, Ageing, AD, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Conference, FAAN, Food, Disease, Medical device, Medical imaging

C2N Diagnostics , a leader in advanced brain health diagnostics, today announced the release of the PrecivityAD2 blood test , a clinical care assay that meets the standard of care with currently available PET scans and cerebrospinal fluid tests.

Key Points: 
  • C2N Diagnostics , a leader in advanced brain health diagnostics, today announced the release of the PrecivityAD2 blood test , a clinical care assay that meets the standard of care with currently available PET scans and cerebrospinal fluid tests.
  • In a clinical validation study involving two independent cohorts totaling 583 patients with cognitive impairment using amyloid PET as the reference standard, the PrecivityAD2 blood test achieved an overall test performance statistic of 0.94 AUC and 88% accuracy.
  • The PrecivityAD2 blood test simultaneously quantifies specific plasma amyloid beta and tau peptide concentrations to calculate the Aβ42/40 Ratio and p-tau217/np-tau217(p-tau217 Ratio).
  • In this regard, the PrecivityAD2 blood test makes a significant contribution to the diagnosis of patients with Alzheimer’s disease.

Koneksa Launches Academic Collaboration Program for Parkinson’s Disease

Retrieved on: 
Monday, August 14, 2023
Software, Research, Pharmaceutical, Technology, Genetics, Health Technology, Clinical Trials, Science, Biotechnology, Neurology, Other Science, Health, Learning, PD, Doctor of Philosophy, Gait, Oregon Health & Science University, Sleep, Quality of life, Neuroscience, Associate, KAPP, MSCE, Patient, OHSU, Oregon Health and Science University Center for Women's Health, L-DOPA, FAAN, Pharmaceutical industry, Medical imaging, MD, Medicine

Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the first collaboration in the Koneksa Academic Partnership Program for Parkinson’s Disease (KAPP-PD) to incorporate its Neuroscience Toolkit into research programs.

Key Points: 
  • Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the first collaboration in the Koneksa Academic Partnership Program for Parkinson’s Disease (KAPP-PD) to incorporate its Neuroscience Toolkit into research programs.
  • The first collaboration of the KAPP-PD program, with Oregon Health & Science University (OHSU), enables the inclusion of app-and actigraphy-based digital measures and electronic patient reported outcome (ePRO) instruments from Koneksa’s Neuroscience Toolkit into a study comparing short-acting versus long-acting levodopa in Parkinson’s disease.
  • Koneksa’s Neuroscience Toolkit implements a variety of digital assessments that can be combined to collect data for measures of interest.
  • We’re committed to helping to get new and better treatments to patients faster, and that’s a vision that OHSU’s Balance Disorders Laboratory shares.”

Neurocrine Biosciences Announces FDA Approval of INGREZZA® (valbenazine) Capsules for the Treatment of Chorea Associated With Huntington's Disease

Retrieved on: 
Friday, August 18, 2023
Huntington's disease, Maintenance, VMAT2, Chorea, Depression, Pharmacy, Somnolence, Disease, Huntington's Disease Society of America, Neurocrine Biosciences, Quality of life, Medicine, NMS, Hives, Behavior, Rash, HSG, Insomnia, Capsule, LSM, TMC, Patient, McGovern Medical School, Neuroleptic malignant syndrome, SAN, FANA, Suicidal ideation, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, FAAN, Food, Caregiver, Safety, Pharmaceutical industry, Birth control, HD, Neurology

"We are thankful for those in the HD community who helped contribute to this important milestone, and we remain committed to bringing medicines to patients with unmet medical needs for debilitating neurological disorders."

Key Points: 
  • "We are thankful for those in the HD community who helped contribute to this important milestone, and we remain committed to bringing medicines to patients with unmet medical needs for debilitating neurological disorders."
  • In clinical studies in Huntington's disease, treatment-emergent adverse events included somnolence and sedation, urticaria, rash and insomnia.
  • "Data also demonstrated INGREZZA was generally well tolerated and showed clinically meaningful improvement in adults with chorea associated with HD."
  • "The approval of INGREZZA for HD chorea means that people living with HD have a new treatment option to help manage their chorea symptoms, which is a welcomed milestone in efforts to improve care for families affected by HD."

AvaSure TeleSitter® Customer Story Featured in August 31 Webinar

Retrieved on: 
Wednesday, August 9, 2023
Senior, MSN, Bed, Community Health Systems, MBA, Falls, DNP, Votruba, Organization, Hospital, Patient, Patient safety, Nursing, CHS, RN, Health, FAAN, Injury

BELMONT, Mich., Aug. 9, 2023 /PRNewswire/ -- AvaSure, the market leader in acute virtual care and remote safety monitoring, has invited clinical leaders from Community Health Systems (CHS) to discuss how they deployed virtual sitter technology in their affiliated hospitals to help improve patient safety. During the webinar, to be held at 12:30 pm ET on August 31, CHS executives will share insights into their decision to expand virtual sitting.

Key Points: 
  • During the webinar , to be held at 12:30 pm ET on August 31, CHS executives will share insights into their decision to expand virtual sitting.
  • CHS sought to use the technology to help reduce patient falls.
  • "As a large company that has focused on patient safety for years, we were excited to take this step forward with virtual sitting technology," said Dr. Simon.
  • To learn more about the August 31st webinar and to register to attend, click here .

NCSBN Announces First Quarter Passing Rates for Next Generation NCLEX® (NGN) Examination

Retrieved on: 
Thursday, August 3, 2023
Heart, NCLEX, Doctor of Philosophy, Master of Jurisprudence, Patient, NGN, NCSBN, RN, Next Generation, FRCN, Health, FAAN, Nursing

Exam passing rates for April 1 – June 30, 2023, can be found here .

Key Points: 
  • Exam passing rates for April 1 – June 30, 2023, can be found here .
  • NCSBN CEO David Benton RGN, PhD, FRCN, FAAN, comments, “We are very pleased that the launch of NGN was seamless for candidates.
  • The increase in those who passed the exam is a reflection of how well the enhanced test mirrors actual nursing practice.
  • The results from the first quarter show that our collaboration was successful.”

Click Therapeutics Launches Additional Randomized Clinical Study in Migraine, Conducted in Partnership with Syneos Health

Retrieved on: 
Wednesday, August 2, 2023
Health, General Health, Click, Poverty, Migraine, Calcitonin gene-related peptide receptor antagonist, Therapy, Disability, Clinical trial, Light, Tetris effect, CGRP, Doctor of Philosophy, App Store (iOS/iPadOS), Syneos Health, Patient, Nausea, RWE, Digital, United, FDA, Health insurance coverage in the United States, FAAN, Safety, Pharmaceutical industry

Click also recently launched the ReMMi-D study, a phase 3 pivotal registration study in approximately 558 patients, in March (NCT05853900).

Key Points: 
  • Click also recently launched the ReMMi-D study, a phase 3 pivotal registration study in approximately 558 patients, in March (NCT05853900).
  • To execute this latest fully remote trial, Click has selected Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization.
  • Together, Click and Syneos Health are designing and deploying the study, enabling patients to consent, enroll, and receive treatment remotely.
  • This groundbreaking decentralized study represents a significant step forward, empowering migraineurs who have been traditionally overlooked by clinical trials," said Shaheen Lakhan MD, PhD, FAAN, Chief Medical Officer, Click Therapeutics.

Dr. Eileen K. Fry-Bowers, Dean of the University of San Francisco School of Nursing & Health Professions, Joins the CA Assoc. of Colleges of Nursing Board of Directors

Retrieved on: 
Tuesday, August 1, 2023
University, Education, USF, Public, Committee, Research, Medicine, Steering and Policy Committees of the United States House of Representatives, Doctor of Philosophy, Health policy, DNP, CPNP, University of San Francisco School of Nursing and Health Professions, United States Navy Nurse Corps, SAN, JD, School, RN, Policy, Health, FAAN, Nursing

SAN FRANCISCO, Aug. 1, 2023 /PRNewswire-PRWeb/ -- Eileen K. Fry-Bowers, PhD, JD, RN, CPNP, FAAN, dean of the University of San Francisco (USF) School of Nursing and Health Professions, was recently elected to the California Association of Colleges of Nursing (CACN) Board of Directors as chair of the Policy Committee, bringing her leadership and experience to CACN, particularly public advocacy and informing policymakers and health care stakeholders.

Key Points: 
  • Eileen K. Fry-Bowers, PhD, JD, RN, CPNP, FAAN, dean of the University of San Francisco School of Nursing and Health Professions, was recently elected to the California Association of Colleges of Nursing Board of Directors as chair of the Policy Committee, bringing her leadership and experience to CACN, particularly public advocacy and informing policymakers and health care stakeholders.
  • SAN FRANCISCO, Aug. 1, 2023 /PRNewswire-PRWeb/ -- Eileen K. Fry-Bowers, PhD, JD, RN, CPNP, FAAN,
    dean of the University of San Francisco (USF) School of Nursing and Health Professions, was recently elected to the California Association of Colleges of Nursing (CACN) Board of Directors as chair of the Policy Committee, bringing her leadership and experience to CACN, particularly public advocacy and informing policymakers and health care stakeholders.
  • "Nursing education is changing its focus from merely delivering healthcare to developing health and eliminating health inequities.
  • It recognizes that nurses need to be equipped with the necessary skills to provide care tailored to the unique needs of different individuals and communities."